17 related articles for article (PubMed ID: 9813322)
1. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.
Choi JK; Mandeville JB; Chen YI; Grundt P; Sarkar SK; Newman AH; Jenkins BG
Psychopharmacology (Berl); 2010 Sep; 212(1):59-72. PubMed ID: 20628733
[TBL] [Abstract][Full Text] [Related]
2. Chronic phenmetrazine treatment promotes D
Keegan BM; Dreitzler AL; Sexton T; Beveridge TJR; Smith HR; Miller MD; Blough BE; Porrino LJ; Childers SR; Howlett AC
Brain Res; 2021 Feb; 1761():147387. PubMed ID: 33631209
[TBL] [Abstract][Full Text] [Related]
3. Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilization.
Richards TL; Pazdernik TL; Levant B
Brain Res; 2007 Jul; 1160():124-33. PubMed ID: 17573047
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
Levant B; Garimelli B; Shafer RA; Merchant KM
Neuropsychopharmacology; 1999 Aug; 21(2):304-11. PubMed ID: 10432478
[TBL] [Abstract][Full Text] [Related]
5. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
6. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
Gyertyán I; Sághy K
Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
[TBL] [Abstract][Full Text] [Related]
8. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Maj J; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
[TBL] [Abstract][Full Text] [Related]
9. Alterations in local cerebral glucose utilization produced by D3 dopamine receptor-selective doses of 7-OH-DPAT and nafadotride.
Levant B; Cross RS; Pazdernik TL
Brain Res; 1998 Nov; 812(1-2):193-9. PubMed ID: 9813322
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
